title: Systemic microvascular dysfunction and inflammation after pulmonary particulate matter exposure.
abstract: The epidemiologic association between pulmonary exposure to ambient particulate matter (PM) and cardiovascular dysfunction is well known, but the systemic mechanisms that drive this effect remain unclear. We have previously shown that acute pulmonary exposure to PM impairs or abolishes endothelium-dependent arteriolar dilation in the rat spinotrapezius muscle. The purpose of this study was to further characterize the effect of pulmonary PM exposure on systemic microvascular function and to identify local inflammatory events that may contribute to these effects. Rats were intratracheally instilled with residual oil fly ash (ROFA) or titanium dioxide at 0.1 or 0.25 mg/rat 24 hr before measurement of pulmonary and systemic microvascular responses. In vivo microscopy of the spinotrapezius muscle was used to study systemic arteriolar responses to intraluminal infusion of the Ca2+ ionophore A23187 or iontophoretic abluminal application of the adrenergic agonist phenylephrine (PHE). Leukocyte rolling and adhesion were quantified in venules paired with the studied arterioles. Histologic techniques were used to assess pulmonary inflammation, characterize the adherence of leukocytes to systemic venules, verify the presence of myeloperoxidase (MPO) in the systemic microvascular wall, and quantify systemic microvascular oxidative stress. In the lungs of rats exposed to ROFA or TiO2, changes in some bronchoalveolar lavage markers of inflammation were noted, but an indication of cellular damage was not found. In rats exposed to 0.1 mg ROFA, focal alveolitis was evident, particularly at sites of particle deposition. Exposure to either ROFA or TiO2 caused a dose-dependent impairment of endothelium-dependent arteriolar dilation. However, exposure to these particles did not affect microvascular constriction in response to PHE. ROFA and TiO2 exposure significantly increased leukocyte rolling and adhesion in paired venules, and these cells were positively identified as polymorphonuclear leukocytes (PMNLs). In ROFA- and TiO2-exposed rats, MPO was found in PMNLs adhering to the systemic microvascular wall. Evidence suggests that some of this MPO had been deposited in the microvascular wall. There was also evidence for oxidative stress in the microvascular wall. These results indicate that after PM exposure, the impairment of endothelium-dependent dilation in the systemic microcirculation coincides with PMNL adhesion, MPO deposition, and local oxidative stress. Collectively, these microvascular observations are consistent with events that contribute to the disruption of the control of peripheral resistance and/or cardiac dysfunction associated with PM exposure.
authors.affiliation: Department of Physiology and Pharmacology, West Virginia University School of Medicine, Morgantown, West Virginia 26506-9229, USA. tnurkiewicz@hsc.wvu.edu
authors.forename: Timothy R
authors.initials: TR
authors.lastname: Nurkiewicz
authors.forename: Dale W
authors.initials: DW
authors.lastname: Porter
authors.forename: Mark
authors.initials: M
authors.lastname: Barger
authors.forename: Lyndell
authors.initials: L
authors.lastname: Millecchia
authors.forename: K Murali K
authors.initials: KM
authors.lastname: Rao
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Marvar
authors.forename: Ann F
authors.initials: AF
authors.lastname: Hubbs
authors.forename: Vincent
authors.initials: V
authors.lastname: Castranova
authors.forename: Matthew A
authors.initials: MA
authors.lastname: Boegehold
mesh_terms: D000393:Air Pollutants / Q000633:toxicity*; D000418:Albumins / Q000032:analysis; D000818:Animals; D001160:Arterioles / Q000187:drug effects / Q000503:physiopathology; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry / Q000166:cytology; D000001:Calcimycin / Q000494:pharmacology; D002244:Carbon / Q000633:toxicity; D060729:Coal Ash; D007249:Inflammation / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008168:Lung / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D016676:Macrophages, Alveolar / Q000187:drug effects / Q000378:metabolism; D008297:Male; D009504:Neutrophils / Q000187:drug effects / Q000201:enzymology; D052638:Particulate Matter; D009195:Peroxidase / Q000378:metabolism; D010656:Phenylephrine / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D017382:Reactive Oxygen Species / Q000378:metabolism; D014025:Titanium / Q000633:toxicity; D014661:Vasoconstriction / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
chemical_list: D000393:Air Pollutants; D000418:Albumins; D060729:Coal Ash; D052638:Particulate Matter; D017382:Reactive Oxygen Species; C009495:titanium dioxide; D010656:Phenylephrine; D000001:Calcimycin; D002244:Carbon; D014025:Titanium; D007770:L-Lactate Dehydrogenase; D009195:Peroxidase